The Beautiful Way Foundation

What The Beautiful Way Foundation does

The Beautiful Way Foundation (TBW) is a 501(c)(3) nonprofit organization founded in 2024 and headquartered in Pittsfield, Massachusetts, with operations in the Greater Boston area. The foundation advances health equity by providing person-centered care, community outreach, education, advocacy, and collaborations in clinical research for underrepresented populations. Its four-pillar operating framework covers community engagement and health advocacy, influencing clinical trial science and policy, collaborating with the life sciences industry, and building strategic partnerships with nonprofits and public health agencies.

TBW delivers its mission through a portfolio of community-facing programs rather than a discrete technology product. Core offerings include Community Health Expos delivering free medical, dental, vision, and mental health services; the annual Convergence Summit convening biotech, healthcare, community, and government stakeholders around FDA Diversity Action Plans; Voices of Progress community listening sessions; Community Membership Enrollment; a Sponsorship Program with $5,000/$10,000 tiers; a Donations Platform via Raisely; and a Strategic Partnership Program targeting trial sponsors, CROs, and patient advocacy groups. The underlying technology is described as data analytics and community outreach platform capabilities, though no proprietary technology stack is publicly detailed.

TBW's revenue model is that of a community-centered nonprofit. Income derives from individual donations, corporate event sponsorships at defined tiers, and strategic partnership services with life sciences firms seeking to improve diversity and inclusion in clinical trials. The go-to-market motion is community-led: culturally tailored outreach to underrepresented populations combined with strategic alliances into pharma, biotech, CROs, and academia. TBW has assembled an advisory board drawing senior figures from Sanofi, Dana-Farber Cancer Institute/Harvard Medical School, HepQuant, Verisense Health, UGenome AI, 3cubed.ai, and other life sciences organizations, signaling intent to bridge community trust with industry clinical research programs.

Name

The Beautiful Way Foundation

Legal name

The Beautiful Way Foundation

Website

https://beautifulway.org

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

The Beautiful Way Foundation is a 501(c)(3) nonprofit that advances health equity for underrepresented communities through community outreach, education, advocacy, and clinical trial partnerships with life sciences companies, CROs, and academic institutions.

Ownership category

akta.pro rank

Product category

Health Equity Nonprofit Services

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Social Advocacy Organizations (8133)

SIC

Services-Health Services (8000), Services-Membership Organizations (8600)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industry

Private Foundations (BPAGAKAA)

Keywords

• Health equity nonprofit
• Clinical trial diversity
• Community health outreach
• Underrepresented populations advocacy
• Community health events

Headquarters

HQ city

Pittsfield

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Donations: Tax-deductible charitable donations from individuals supporting health equity mission and community programs
2. Sponsorships: Corporate sponsorships for events at tiers of $5,000, $10,000, or custom amounts, providing logo placement, digital recognition, social media mentions, and event access
3. Strategic Partnership Services: Collaboration opportunities for trial sponsors, CROs, clinical research partners, patient advocacy groups, and community organizations seeking to advance inclusive clinical trial participation

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The Beautiful Way Foundation is a 501(c)(3) nonprofit that advances health equity through free community health events (Community Health Expos, Megaclinics, Community Power Expos providing medical, dental, and vision services), an annual Convergence Summit for industry and community leaders, Voices of Progress listening sessions, a Strategic Partnership Program for life sciences collaborators, and a Community Membership Enrollment program. Services are provided free of charge to community members while engaging pharmaceutical, biotech, and CRO partners through sponsorships and co-creative collaboration initiatives.

Product overview

The Beautiful Way Foundation is a 501(c)(3) nonprofit organization that does not offer a technology product in the traditional sense. Its services consist of community health equity programs: Community Health Expos providing free medical/dental/vision services; the annual Convergence Summit addressing clinical trial diversity; Voices of Progress community listening sessions; a Strategic Partnership Program for industry and community collaboration; Community Membership Enrollment; a Sponsorship Program for event support; and a Donations Platform via Raisely. These programs collectively advance TBW's mission of dismantling healthcare disparities and fostering inclusive access to clinical trials for underrepresented communities.

Differentiator

Problem solved

Functional benefit

Products and services

• Community Health Expos
• Convergence Summit
• Voices of Progress
• Strategic Partnership Program
• Community Membership Enrollment
• Sponsorship Program
• Donations Platform

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

18 partnerships are on record, tiered core and secondary.

• Whittier Street Health CentercoreStrategic or Co-development PartnerHost venue for Roxbury's 2nd Community Power Expo event, providing free medical, dental, and vision services along with mental health support, clothing, and food assistance to community members. A key community health center serving underrepresented populations in Roxbury, MA.
• Portal InnovationscoreStrategic or Co-development PartnerHost venue for The Beautiful Way 1st Annual Convergence Summit at Southline Boston location. A life sciences incubator and innovation hub supporting the foundation's equity-focused clinical trial initiatives.
• SanoficoreStrategic or Co-development PartnerDr. Gopi Nageshwaran serves as Global Medical Evidence Generation Lead-Immunology at Sanofi and is a member of TBW's Advisory Board, providing industry expertise in clinical research and drug development.
• Life Sciences Industry PartnerscoreStrategic or Co-development PartnerTBW forges co-creative partnerships with pharmaceutical companies, biotech firms, CROs, and academic institutions to integrate community voices into every stage of drug development through joint pilot programs, advisory councils, and recruitment initiatives.
• Dana-Farber Cancer Institute / Harvard Medical SchoolcoreStrategic or Co-development PartnerDr. Andrew Hantel, Assistant Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, serves on TBW's Advisory Board, contributing expertise in cancer health equity and clinical trial ethics.
• Nonprofits and Public Health AgenciescoreStrategic or Co-development PartnerStrategic alliances with nonprofits, public health agencies, advocacy groups, and funders to build a sustainable ecosystem of support. TBW aligns resources, expertise, and networks to enable scalable programs that dismantle barriers and foster holistic well-being.
• Emily Whitehead FoundationsecondaryStrategic or Co-development PartnerGeorge Eastwood, Board Chair & Executive Director of the Emily Whitehead Foundation, serves as an organizer for TBW's Annual Convergence Summit, bringing expertise in patient advocacy and foundation leadership.
• KMAK CapitalsecondaryStrategic or Co-development PartnerLynn Fischer, CEO, Managing Director and Chief Negotiator of KMAK Capital, serves as an organizer for TBW's Annual Convergence Summit, contributing financial and strategic expertise.
• AKT Health Inc.secondaryStrategic or Co-development PartnerDavid Hall, Managing Director of AKT Health Inc., serves as an organizer for TBW's Annual Convergence Summit and member of TBW's Advisory Board.
• Yoanne Clovis, LLCsecondaryStrategic or Co-development PartnerDr. Yoanne Clovis, Founder of Yoanne Clovis, LLC, serves on TBW's Advisory Board with expertise in biotech brand strategy and scientific communication.
• HepQuantsecondaryStrategic or Co-development PartnerDr. Shailesh Shavon, Chief Medical Officer at HepQuant, serves on TBW's Advisory Board with over 24 years of biopharma experience in clinical research and drug development.
• 3cubed.aisecondaryStrategic or Co-development PartnerDr. Noriko Yokoi, Founding Partner at 3cubed.ai (AI Workforce company), serves on TBW's Advisory Board contributing expertise in healthcare product launches and digital transformation.
• Verisense HealthsecondaryStrategic or Co-development PartnerGeoffrey Gill, Founder & CEO of Verisense Health (digital health firm), serves on TBW's Advisory Board with expertise in digital health, clinical trials, and wearables.
• UGenome AIsecondaryStrategic or Co-development PartnerDr. Zachary S. Brooks, Founder & CEO of UGenome AI, serves on TBW's Advisory Board with expertise in genomic medicine and personalized treatment.
• LinkCosecondaryStrategic or Co-development PartnerJaynee Sasso, CEO of LinkCo, serves on TBW's Advisory Board with expertise in senior care, healthcare transformation, and addressing social determinants of health.
• Sugarloaf CapitalsecondaryStrategic or Co-development PartnerJimi Olaghere, Co-founder of Sugarloaf Capital, serves as an organizer for TBW's Annual Convergence Summit, contributing venture capital and startup expertise.
• MazzettisecondaryStrategic or Co-development PartnerTroy Savage, Managing Director & Project Manager at Mazzetti, serves on TBW's Advisory Board contributing expertise in project management and healthcare facility design.
• Liberty and Health Association (LHA)coreStrategic or Co-development PartnerCollaborative partner for the LHA Megaclinic mission to Asheville, NC, providing free medical, dental, and vision care while supporting hurricane relief efforts for communities affected by Hurricane Helene.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Susan G. Komen Foundation: Susan G. Komen is a large health nonprofit funding breast cancer research, community outreach, and patient navigation including clinical trial access. It is a broad incumbent that competes for pharma and corporate sponsorship dollars in the same health-equity advocacy space.
• Robert Wood Johnson Foundation: Robert Wood Johnson Foundation is one of the largest US health-focused foundations, funding health-equity research, community health, and policy work nationwide. It is a broad incumbent because it funds and shapes the same health-equity space at a vastly larger scale.

Emerging players

• Acclinate: Acclinate is a health-equity company that uses community engagement and a proprietary database to increase diversity in clinical trials. It is an emerging peer because it serves the same sponsor use case as TBW but combines nonprofit-style community work with commercial technology.

Direct peers

• Lazarex Cancer Foundation: Lazarex Cancer Foundation is a 501(c)(3) that helps cancer patients — particularly from underrepresented communities — navigate clinical trial enrollment, covering costs and providing community outreach. It is a direct peer because it operates the same clinical-trial-diversity nonprofit model with pharma partnership revenue.
• Sick Cells: Sick Cells is a sickle-cell disease advocacy nonprofit that elevates patient voices in clinical research and drug development. It is a direct peer because it works on community-rooted clinical-trial participation, similar to TBW's disease-focused community engagement.
• CISCRP (Center for Information and Study on Clinical Research Participation): CISCRP is a nonprofit dedicated to educating the public and patients about clinical trial participation and diversity. It is a direct peer because it serves the same mission of broadening community engagement in clinical research and works with pharma sponsors.
• Black Women's Health Imperative: Black Women's Health Imperative is a national health-equity nonprofit that advocates for and educates Black women on health issues including clinical research participation. It is a direct peer in the community-rooted health-equity and clinical-trial-advocacy space.
• Emily Whitehead Foundation: Emily Whitehead Foundation is a pediatric-cancer patient-advocacy nonprofit that engages pharma, researchers, and families to expand access to clinical trials. It is a direct peer and a current TBW partner; its board chair (George Eastwood) is organizing TBW's Convergence Summit.
• National Patient Advocate Foundation: National Patient Advocate Foundation is a patient-advocacy nonprofit that engages policymakers and industry to improve access to clinical trials and affordable care. It is a direct peer with overlapping community, policy, and industry-engagement pillars.

Others

• Clinical Trials Transformation Initiative (CTTI): CTTI is a public-private partnership co-founded by Duke and FDA that develops recommendations to improve clinical trial quality and efficiency. It is comparable as an ecosystem convener working on trial reform, though it focuses on policy/methodology rather than direct community delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/TheBeautifulWayFoundation
• LinkedInlinkedin.com/company/the-beautiful-way

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Beautiful Way Foundation